4Deng Z, Hu B J, He L X, el aL. A muhicenter prospevtive cohort study on risk factors tor hospital-acquired pneumonia in the elderly [J]. Zhonghua Nei Ke Za Zhi,2008,47(1) :31-35.
5Chong C P, Street P R. Pneumonia in the elderly: ,4 review of the epidemiology, pathogenesis,microbiology, anti clinical features [J ]. South Med J, 2008,101 ( 11 ) : 1141 - l 145.
6Masterton R G, Galloway A, French G, et al. Guidelines for the managemem of hospital- acquired pneumonia in the UK: Report of the Working Party on Hospital-Acquired Pneumonia of the British Society for Antimicrobial Chemotherapy [J]. J Antimic Chem, 2008,62 ( 1 ) : 5-34.
7Pate] U, Yan Y P, Hobbs F W Jr, et al. Oxazolidinones mechanism of action:inhibition of the first peptide bond tbrmation [J]. J Biol Chem, 2001 , 276(8,0) : 37199-3720.5.
8Shorr A F, Kunkel M J, Kollef M. Linezotid wersus vancomycin for Staphylococcus aureus bacteraemia:Pooled analysis of randomized studies [J]. J Antimicrob Chemother, 2005,56 (5) : 923-929.
